DMAC position history
The shares of Diamedica Therapeutics (DMAC) that Omega Advisors reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 200,000 shares, $802K, 0.04% of portfolio
- 2021 Q4: 300,000 shares, $1.1M, 0.06% of portfolio, Add +50.0%
- 2022 Q1: 812,508 shares, $2M, 0.11% of portfolio, Add +170.8%
- 2022 Q2: 812,508 shares, $1.6M, 0.11% of portfolio
- 2022 Q3: 812,508 shares, $1M, 0.07% of portfolio
- 2022 Q4: 812,508 shares, $1.3M, 0.08% of portfolio
- 2023 Q1: 868,413 shares, $1.3M, 0.08% of portfolio, Add +6.9%
- 2023 Q2: 875,993 shares, $3.8M, 0.21% of portfolio, Add +0.9%
- 2023 Q3: 875,993 shares, $2.3M, 0.12% of portfolio
- 2023 Q4: 1,767,246 shares, $5M, 0.24% of portfolio, Add +101.7%
- 2024 Q1: 883,623 shares, $2.4M, 0.10% of portfolio, Reduce −50.0%
- 2024 Q2: 1,400,000 shares, $4.1M, 0.17% of portfolio, Add +58.4%
- 2024 Q3: 1,511,739 shares, $6.3M, 0.27% of portfolio, Add +8.0%
- 2024 Q4: 1,625,000 shares, $8.8M, 0.33% of portfolio, Add +7.5%
- 2025 Q1: 3,250,000 shares, $12M, 0.49% of portfolio, Add +100.0%
- 2025 Q2: 1,650,000 shares, $6.4M, 0.23% of portfolio, Reduce −49.2%
- 2025 Q3: 3,269,761 shares, $18M, 0.55% of portfolio, Add +98.2%
- 2025 Q4: 2,020,000 shares, $16M, 0.53% of portfolio, Reduce −38.2%
- 2026 Q1: 2,020,000 shares, $14M, 0.45% of portfolio
- 2026 Q2: 3,450,000 shares, $24M, 0.68% of portfolio, Add +70.8%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|